Director/PDMR Shareholding

RNS Number : 4694M
Synthomer PLC
11 May 2020
 

LEI: 213800EHT3TI1KPQQJ56

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 On 6 May 2020 Calum MacLean, Chief Executive Officer, Synthomer plc ("the Company"), exercised a nil cost long term incentive plan award over 17,316 ordinary shares granted in 2017 under the Company's 2011 Performance Share Plan. Mr MacLean has retained all such shares and will pay the cost of the resultant tax liability in cash in order to avoid the disposal of any shares.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Calum MacLean

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Synthomer plc

b)

 

LEI

 

 

213800EHT3TI1KPQQJ56

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each



Identification code

GB0009887422



b)

 

Nature of the transaction

 

 

Exercise of long term incentive plan award granted in 2017 under the 2011 Performance Share Plan

 

 

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




Nil

17,316







d)

 

Aggregated information




- Aggregated volume

17,316



- Price

Nil



e)

 

Date of the transaction

 

 

6 May 2020

f)

 

Place of the transaction

 

 

Not applicable

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHEAPSFFEEEEEA

Companies

Synthomer (SYNT)
Investor Meets Company
UK 100